We are live on
!
Find out more
ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
318 hedge funds and large institutions have $10.5B invested in Array Biopharma Inc in 2019 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 69 increasing their positions, 96 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
115% more funds holding in top 10
Funds holding in top 10: 13 → 28 (+15)
92% more capital invested
Capital invested by funds: $5.5B → $10.5B (+$5.05B)
77% more first-time investments, than exits
New positions opened: 126 | Existing positions closed: 71
19% more funds holding
Funds holding: 268 → 318 (+50)
12% less call options, than puts
Call options by funds: $141M | Put options by funds: $160M
28% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 96
Holders
318
Holders Change
+50
Holders Change %
+18.66%
% of All Funds
6.91%
Holding in Top 10
28
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+115.38%
% of All Funds
0.61%
New
126
Increased
69
Reduced
96
Closed
71
Calls
$141M
Puts
$160M
Net Calls
-$19M
Net Calls Change
-$88M
Top Buyers
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
+$163M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$106M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
+$96.8M |
| 4 |
PC
Paulson & Co
New York
|
+$92M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$90M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$368M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$225M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$155M |
| 4 |
PA
Perceptive Advisors
New York
|
-$89.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$77.4M |
